Koinis, F.; Corn, P.; Parikh, N.; Song, J.; Vardaki, I.; Mourkioti, I.; Lin, S.-H.; Logothetis, C.; Panaretakis, T.; Gallick, G.
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer. Cancers 2020, 12, 244.
https://doi.org/10.3390/cancers12010244
AMA Style
Koinis F, Corn P, Parikh N, Song J, Vardaki I, Mourkioti I, Lin S-H, Logothetis C, Panaretakis T, Gallick G.
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer. Cancers. 2020; 12(1):244.
https://doi.org/10.3390/cancers12010244
Chicago/Turabian Style
Koinis, Filippos, Paul Corn, Nila Parikh, Jian Song, Ioulia Vardaki, Ioanna Mourkioti, Sue-Hwa Lin, Christopher Logothetis, Theocharis Panaretakis, and Gary Gallick.
2020. "Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer" Cancers 12, no. 1: 244.
https://doi.org/10.3390/cancers12010244
APA Style
Koinis, F., Corn, P., Parikh, N., Song, J., Vardaki, I., Mourkioti, I., Lin, S. -H., Logothetis, C., Panaretakis, T., & Gallick, G.
(2020). Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer. Cancers, 12(1), 244.
https://doi.org/10.3390/cancers12010244